Page last updated: 2024-10-24

candesartan cilexetil and Impaired Glucose Tolerance

candesartan cilexetil has been researched along with Impaired Glucose Tolerance in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Research Excerpts

ExcerptRelevanceReference
"We have previously demonstrated that captopril ameliorates glucose intolerance by partially preventing the reduction in postprandial skeletal muscle blood flow."7.69Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. ( Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I, 1996)
"We have previously demonstrated that captopril ameliorates glucose intolerance by partially preventing the reduction in postprandial skeletal muscle blood flow."3.69Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. ( Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S1
Kashiwabara, H1
Kosegawa, I1
Ishii, J1
Katayama, S1

Other Studies

1 other study available for candesartan cilexetil and Impaired Glucose Tolerance

ArticleYear
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1996, Volume: 18, Issue:5

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv

1996